Financial Performance Overview: FY2025 and Q4
Annual Highlights (FY2025)
- Total Revenue: $1.21 billion (₹10,274 crores), up 18% YoY
- EBITDA: $226.7 million (₹1,925 crores), up 50% YoY
- Net Profit (PAT): $111 million (₹945 crores), up 102% YoY
- EBITDA Margin: Improved from 15% to 19%
- Net Debt: Reduced to $388.1 million (₹3,305 crores) from $402.8 million (₹3,426 crores); Net Debt/EBITDA down to 1.72x from 2.66x
Q4 FY2025 Highlights
- Revenue: $313.2 million (₹2,667 crores), up 28% YoY
- EBITDA: $56.4 million (₹480 crores), up 10% YoY
- Net Profit: $32.7 million (₹278 crores), up 21% YoYFRED
Strategic Business Transformations
Shift from Commodity to Specialty Products
Deepak Fertilisers has continued its strategic transformation from a commodity-led model to a specialty and solution-focused enterprise. The share of specialty products in total operating revenue rose to 22% in FY2025 from 17% in FY2024, reflecting a 51% YoY growth. This transition is central to improving margins, innovation leadership, and sustainable growth.
Segment-Wise Performance
1. Crop Nutrition Business (CNB)
- Bulk Fertilizers: Manufactured sales volume increased by 68% YoY in Q4 FY25, totaling 888 KMT for FY25. Including traded bulk, the company crossed 1 Million MT for the first time.
- Specialty Fertilizers:
- Croptek: +111% YoY growth in Q4
- Smartek: +83% YoY growth
- Bensulf & WSF: Manufactured specialty fertilizer up 40% YoY; traded volumes flat due to market volatility
Above-normal monsoons and growing adoption of crop-specific nutrients fueled performance. The “MAHADHAN” brand gained strong traction in core crops like cotton, soybean, paddy, and corn.
2. Mining Chemicals (Technical Ammonium Nitrate – TAN)
- LDAN (Low-Density Ammonium Nitrate):
- Q4 FY25 sales volume: +11% YoY
- FY25 sales volume: +15%
Existing TAN plants are near full capacity; Gopalpur project is at 75% completion. India’s growth in coal mining, steel, and cement sectors continues to drive demand.
3. Pharma & Specialty Chemicals
- IPA (Isopropyl Alcohol):
- Q4 volume down 27% YoY, due to planned plant shutdown for process improvements
- FY25 volume down 5% YoY
- Nitric Acid:
- Q4 FY25 volumes: +29% YoY
- FY25: +3% YoY
Process upgrades are now complete, with full operations restored. Despite weak Acetone and IPA markets, the specialty product line is receiving positive customer feedback.
Project Updates
- Gopalpur TAN Project: 75% complete
- Dahej Nitric Acid Project: 48% complete
- All key statutory approvals and critical equipment deliveries in progress
- Strategic location minimizes raw material and offtake risk
Capital Allocation and Balance Sheet
- FY25 Capex: $77 million (₹655 crores)
- CCDs worth $94 million (₹800 crores) raised via subsidiary DMSL
- Net debt reduced; financials supported by healthy operational cash flows
Management Commentary and Outlook
S.C. Mehta, CMD, emphasized the company’s transformation and readiness for a new growth phase. With a strong R&D pipeline, completion of major capex by H2 FY26, and robust demand outlook across sectors, DFPCL is well-positioned to scale up.
Anticipated above-normal monsoon, increased mining and infrastructure activity, and expanding pharma/chemical demand underpin a positive FY26 outlook.
